Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/23897166/ below:

Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation

Review

Affiliations

• ¹ From Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, and Portland Veterans Affairs Medical Center, Portland, Oregon.

• PMID: 23897166
• DOI: 10.7326/0003-4819-159-6-201309170-00690

Item in Clipboard

Review

Linda L Humphrey et al. Ann Intern Med. 2013.

• ¹ From Pacific Northwest Evidence-based Practice Center, Oregon Health & Science University, and Portland Veterans Affairs Medical Center, Portland, Oregon.

• PMID: 23897166
• DOI: 10.7326/0003-4819-159-6-201309170-00690

Item in Clipboard

Background: Lung cancer is the leading cause of cancer-related death in the United States. Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection and treatment may be beneficial.

Purpose: To update the 2004 review of screening for lung cancer for the U.S. Preventive Services Task Force, focusing on screening with low-dose computed tomography (LDCT).

Data sources: MEDLINE (2000 to 31 May 2013), the Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2012), Scopus, and reference lists.

Study selection: English-language randomized, controlled trials or cohort studies that evaluated LDCT screening for lung cancer.

Data extraction: One reviewer extracted study data about participants, design, analysis, follow-up, and results, and a second reviewer checked extractions. Two reviewers rated study quality using established criteria.

Data synthesis: Four trials reported results of LDCT screening among patients with smoking exposure. One large good-quality trial reported that screening was associated with significant reductions in lung cancer (20%) and all-cause (6.7%) mortality. Three small European trials showed no benefit of screening. Harms included radiation exposure, overdiagnosis, and a high rate of false-positive findings that typically were resolved with further imaging. Smoking cessation was not affected. Incidental findings were common.

Limitations: Three trials were underpowered and of insufficient duration to evaluate screening effectiveness. Overdiagnosis, an important harm of screening, is of uncertain magnitude. No studies reported results in women or minority populations.

Conclusion: Strong evidence shows that LDCT screening can reduce lung cancer and all-cause mortality. The harms associated with screening must be balanced with the benefits.

Primary funding source: Agency for Healthcare Research and Quality.

PubMed Disclaimer

• ACP Journal Club. Review: low-dose CT screening reduces lung cancer and mortality in current or former smokers.

  Lathan C, Frank DA. Lathan C, et al. Ann Intern Med. 2013 Nov 19;159(10):JC3. doi: 10.7326/0003-4819-159-10-201311190-02003. Ann Intern Med. 2013. PMID: 24247693 No abstract available.

• Screening for lung cancer with low-dose computed tomography.

  Brodersen J, Rasmussen JF, Heleno B. Brodersen J, et al. Ann Intern Med. 2014 Feb 4;160(3):211. doi: 10.7326/L14-5003. Ann Intern Med. 2014. PMID: 24493447 No abstract available.

• Screening for lung cancer with low-dose computed tomography.

  Humphrey LL, Deffebach M, Pappas M, Zakher B, Slatore CG. Humphrey LL, et al. Ann Intern Med. 2014 Feb 4;160(3):212. doi: 10.7326/L14-5003-3. Ann Intern Med. 2014. PMID: 24493448 No abstract available.

• Lung cancer screening with low-dose CT (LDCT) is ready for prime time in the USA.

  Wilson DO. Wilson DO. Evid Based Med. 2014 Aug;19(4):150. doi: 10.1136/eb-2013-101611. Epub 2014 Mar 13. Evid Based Med. 2014. PMID: 24627174 No abstract available.

• Screening for lung cancer with low-dose computed tomography.

  Brodersen J, Dirksen A, Pedersen JH. Brodersen J, et al. Ann Intern Med. 2014 Feb 4;160(3):212. doi: 10.7326/L14-5003-2. Ann Intern Med. 2014. PMID: 24658700 No abstract available.

• Low-dose computed tomography screening for lung cancer.

  Welch LS, Madtes D, Ringen K. Welch LS, et al. Ann Intern Med. 2015 Mar 17;162(6):459-60. doi: 10.7326/L15-5065. Ann Intern Med. 2015. PMID: 25775330 No abstract available.

• Low-dose computed tomography screening for lung cancer.

  Wiener RS. Wiener RS. Ann Intern Med. 2015 Mar 17;162(6):460. doi: 10.7326/L15-5065-2. Ann Intern Med. 2015. PMID: 25775331 No abstract available.

• Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

  Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, Enyioha C, Malo TL, Brenner AT, Armstrong C, Coker-Schwimmer M, Middleton JC, Voisin C, Harris RP. Jonas DE, et al. JAMA. 2021 Mar 9;325(10):971-987. doi: 10.1001/jama.2021.0377. JAMA. 2021. PMID: 33687468

• Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.

  Pillay J, Rahman S, Klarenbach S, Reynolds DL, Tessier LA, Thériault G, Persaud N, Finley C, Leighl N, McInnes MDF, Garritty C, Traversy G, Tan M, Hartling L. Pillay J, et al. Syst Rev. 2024 Mar 16;13(1):88. doi: 10.1186/s13643-024-02506-3. Syst Rev. 2024. PMID: 38493159 Free PMC article.

• Lung cancer screening.

  Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Tanoue LT, et al. Am J Respir Crit Care Med. 2015 Jan 1;191(1):19-33. doi: 10.1164/rccm.201410-1777CI. Am J Respir Crit Care Med. 2015. PMID: 25369325 Review.

• Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.

  Slatore CG, Baumann C, Pappas M, Humphrey LL. Slatore CG, et al. Ann Am Thorac Soc. 2014 May;11(4):619-27. doi: 10.1513/AnnalsATS.201312-460OC. Ann Am Thorac Soc. 2014. PMID: 24701999 Review.

• Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation.

  Nelson HD, Pappas M, Cantor A, Griffin J, Daeges M, Humphrey L. Nelson HD, et al. Ann Intern Med. 2016 Feb 16;164(4):256-67. doi: 10.7326/M15-0970. Epub 2016 Jan 12. Ann Intern Med. 2016. PMID: 26756737 Review.

• Utility of incorporating a gene-based lung cancer risk test on uptake and adherence in a community-based lung cancer screening pilot study.

  Lam VK, Scott RJ, Billings P, Cabebe E, Young RP. Lam VK, et al. Prev Med Rep. 2021 May 16;23:101397. doi: 10.1016/j.pmedr.2021.101397. eCollection 2021 Sep. Prev Med Rep. 2021. PMID: 34040933 Free PMC article.

• Using a Patient Decision Aid Video to Assess Current and Former Smokers' Values About the Harms and Benefits of Lung Cancer Screening With Low-Dose Computed Tomography.

  Hoffman AS, Hempstead AP, Housten AJ, Richards VF, Lowenstein LM, Leal VB, Volk RJ. Hoffman AS, et al. MDM Policy Pract. 2018 Apr 19;3(1):2381468318769886. doi: 10.1177/2381468318769886. eCollection 2018 Jan-Jun. MDM Policy Pract. 2018. PMID: 30288444 Free PMC article.

• A way forward for cancer prevention therapy: personalized risk assessment.

  Zhang Z, Bien J, Mori M, Jindal S, Bergan R. Zhang Z, et al. Oncotarget. 2019 Dec 3;10(64):6898-6912. doi: 10.18632/oncotarget.27365. eCollection 2019 Dec 3. Oncotarget. 2019. PMID: 31839883 Free PMC article.

• Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco.

  Bilenduke E, Anderson S, Brenner A, Currier J, Eberth JM, King J, Land SR, Risendal BC, Shannon J, Siegel LN, Wangen M, Waters AR, Zahnd WE, Studts JL. Bilenduke E, et al. Cancer Causes Control. 2023 Dec;34(Suppl 1):209-216. doi: 10.1007/s10552-023-01790-z. Epub 2023 Sep 15. Cancer Causes Control. 2023. PMID: 37713024 Free PMC article.

• An integromic signature for lung cancer early detection.

  Leng Q, Lin Y, Zhan M, Jiang F. Leng Q, et al. Oncotarget. 2018 May 15;9(37):24684-24692. doi: 10.18632/oncotarget.25227. eCollection 2018 May 15. Oncotarget. 2018. PMID: 29872497 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3